Cardiac arrest is a major health problem that carries a high mortality rate. Substantial research and development have been put into changing the outcome of cardiac arrest and despite the advent of automated external defibrillators (AED), increase in bystander Cardiopulmonary resuscitation (CPR) and automated CPR devices (ACPR), the proportion of patient survival to hospital discharge has only minimally improved. The objective is to investigate safety and performance of the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) procedure as an adjunct to Advanced Life Support (ALS) for treatment of refractory cardiac arrest.
The scope of the study is to collect data on patients with refractory out of hospital cardiac arrest (OHCA) for this feasibility study. Data collected: * from enrolment of the patient until hospital arrival * every 24 hours * at discharge or 7 days post enrollment * at 30 days post enrollment The investigation is initiated to investigate the safety and performance of the REBOA procedure for patients experiencing refractory OHCA.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Endovascular balloon occlusion of the aorta
Central blood pressure
Time frame: 1 hour
Return of spontaneous circulation (ROSC)
Time frame: 1 hour
Changes in cardiac rhythm following balloon inflation
Time frame: 1 hour
During procedure - time from first needle stick to successful sheath insertion
Time frame: 1 hour
During procedure - time from first needle stick to finalized balloon inflation
Time frame: 1 hour
End-tidal CO2 (EtCO2)
Time frame: 1 hour
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.